{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:12:07Z","timestamp":1785334327423,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV- 017302"],"award-info":[{"award-number":["INV- 017302"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016056","name":"Minderoo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014607","name":"Royal Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014093","name":"Peter Sowerby Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in the preceding 0-6 months as part of the BCG vaccination to reduce the impact of COVID-19 in healthcare workers (BRACE) trial, we also investigated the influence of recent BCG vaccination on antibody responses to these COVID-19 vaccines. Twenty-eight days after the second dose of each vaccine, ChAdOx1-S induced a stronger anti-spike IgG response than CoronaVac vaccination. Recent BCG vaccination did not impact IgG antibody responses to ChAdOx1-S or CoronaVac.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1172851","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T08:21:31Z","timestamp":1688372491000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination"],"prefix":"10.3389","volume":"14","author":[{"given":"Nicole L.","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana G.","family":"Sperotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A. M.","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia V.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto D.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia L.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure F.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenaya","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareth","family":"Dalcolmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauce","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V. G.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Croda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.12968\/bjon.2021.30.6.344","article-title":"COVID-19 vaccines and vaccine administration","volume":"30","author":"Gordon","year":"2021","journal-title":"Br J Nurs."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00356-23","article-title":"BCG Vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial","volume":"14","author":"Claus","year":"2023","journal-title":"mBio"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01194-5","article-title":"T Cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and T(H)1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2313","article-title":"Covid-19 vaccines and variants of concern: a review","volume":"32","author":"Hadj Hassine","year":"2022","journal-title":"Rev Med Virol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA vaccines in the COVID-19 pandemic and beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu Rev Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"198454","DOI":"10.1016\/j.virusres.2021.198454","article-title":"The COVID-19 vaccine development: a pandemic paradigm","volume":"301","author":"Carneiro","year":"2021","journal-title":"Virus Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.11.009","article-title":"Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis","volume":"114","author":"Zheng","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, south Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(21)00305-0","article-title":"Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study","volume":"3","author":"Barin","year":"2022","journal-title":"Lancet Microbe"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-059994","article-title":"Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis","volume":"12","author":"Ebinger","year":"2022","journal-title":"BMJ Open"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.894277","article-title":"Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries","volume":"13","author":"Romero-Ibarguengoitia","year":"2022","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.01.002","article-title":"Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: an observational study of 646 Japanese healthcare workers and university staff","volume":"40","author":"Uwamino","year":"2022","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145545","article-title":"BCG Vaccination in health care providers and the protection against COVID-19","volume":"131","author":"Netea","year":"2021","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145157","article-title":"BCG Vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers","volume":"131","author":"Rivas","year":"2021","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG vaccine for COVID-19: first verdict and future directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.02.016","article-title":"The impact of vaccines on heterologous adaptive immunity","volume":"25","author":"Messina","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1483727","article-title":"The influence of BCG on vaccine responses - a systematic review","volume":"17","author":"Zimmermann","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1387","article-title":"Off-target effects of bacillus calmette-guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19","volume":"11","author":"Messina","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac182","article-title":"Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic","volume":"75","author":"Moorlag","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052101","article-title":"BCG Vaccination to reduce the impact of COVID-19 in healthcare workers: protocol for a randomised controlled trial (BRACE trial)","volume":"11","author":"Pittet","year":"2021","journal-title":"BMJ Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) covid-19 vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 covid-19 vaccine against the B.1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00628-0","article-title":"Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012\/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial","volume":"397","author":"Emary","year":"2021","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2211314","article-title":"A covid-19 milestone attained - a correlate of protection for vaccines","volume":"387","author":"Gilbert","year":"2022","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.lana.2021.100025","article-title":"Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 gamma variant transmission in manaus, Brazil: a test-negative case-control study","volume":"1","author":"Hitchings","year":"2021","journal-title":"Lancet Reg Health Am"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27604","article-title":"Dynamics of antibody response to CoronaVac vaccine","volume":"94","author":"Fonseca","year":"2022","journal-title":"J Med Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2103825","article-title":"SARS-CoV-2 antibody response in persons with past natural infection","volume":"385","author":"Anichini","year":"2021","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1558","article-title":"Spatiotemporal pattern of COVID-19 spread in Brazil","volume":"372","author":"Castro","year":"2021","journal-title":"Science."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01191-z","article-title":"Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil","volume":"7","author":"Giovanetti","year":"2022","journal-title":"Nat Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010121","article-title":"Non-specific effects of bacillus calmette-guerin: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Trunk","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031154","article-title":"Efficacy of BCG vaccination against COVID-19: systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Wen","year":"2023","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010075","article-title":"A multi-centre, randomised, double-blind, placebo-controlled phase III clinical trial evaluating the impact of BCG re-vaccination on the incidence and severity of SARS-CoV-2 infections among symptomatic healthcare professionals during the COVID-19 pandemic in Poland-evaluation of antibody concentrations","volume":"11","author":"Zapolnik","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn4002","article-title":"Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes","volume":"8","author":"Bannister","year":"2022","journal-title":"Sci Adv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy069","article-title":"Neonatal BCG vaccination influences cytokine responses to toll-like receptor ligands and heterologous antigens","volume":"217","author":"Freyne","year":"2018","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B46","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41541-021-00406-4","article-title":"A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection","volume":"6","author":"Counoupas","year":"2021","journal-title":"NPJ Vaccines"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2200731","article-title":"Recombinant bacillus calmette-guerin expressing SARS-CoV-2 chimeric protein protects K18-hACE2 mice against viral challenge","author":"Mambelli","year":"2023","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2013.12.006","article-title":"Non-tuberculous mycobacteria have diverse effects on BCG efficacy against mycobacterium tuberculosis","volume":"94","author":"Poyntz","year":"2014","journal-title":"Tuberculosis (Edinb)."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz285","article-title":"Nontuberculous mycobacteria and heterologous immunity to tuberculosis","volume":"220","author":"Shah","year":"2019","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2016.142","article-title":"Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial","volume":"80","author":"Kjaergaard","year":"2016","journal-title":"Pediatr Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/infdis\/jiaa030","article-title":"Neonatal BCG vaccination reduces interferon-\u03b3 responsiveness to heterologous pathogens in infants from a randomized controlled trial","volume":"221","author":"Freyne","year":"2020","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"109208","DOI":"10.1016\/j.clim.2022.109208","article-title":"The impact of BCG dose and revaccination on trained immunity","volume":"246","author":"Debisarun","year":"2023","journal-title":"Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30994-4","article-title":"The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi","volume":"21","author":"Glynn","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"c671","DOI":"10.1136\/bmj.c671","article-title":"Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau","volume":"340","author":"Roth","year":"2010","journal-title":"BMJ"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101601","article-title":"Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK)","volume":"10","author":"Jolliffe","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"105044","DOI":"10.1016\/j.micinf.2022.105044","article-title":"Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines","volume":"25","author":"Kung","year":"2023","journal-title":"Microbes Infect"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1172851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T08:21:36Z","timestamp":1688372496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1172851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":58,"alternative-id":["10.3389\/fimmu.2023.1172851"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1172851","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"article-number":"1172851"}}